Reviva Pharmaceuticals Holdings, Inc. (RVPH) Earnings
|
Expand Research on RVPH
| Next EPS Date | 8/17/26 | EPS Growth Rate | -241.7% |
|---|---|---|---|
| Average EPS % Beat Rate | -183.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | 0.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/17/26  |
Q226 | N/A | -$0.41 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/13/26 |
Q126 | -$0.46 | -$0.05 | -$0.41 | N/A | N/A | N/A |  | | Details | |
| 3/23/26 |
Q425 | N/A | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/13/25 |
Q325 | -$0.06 | -$0.10 | +$0.04 | N/A | N/A | N/A | | | Details | |
| 8/14/25 |
Q225 | -$0.12 | -$0.13 | +$0.01 | N/A | N/A | N/A | | | Details | |
| 5/15/25 |
Q125 | -$0.13 | -$0.21 | +$0.08 | N/A | N/A | N/A | | | Details | |
| 3/31/25 | Q424 | -$0.90 | N/A | N/A | N/A | N/A | N/A | | | Details | |
| 3/24/25 |
Q424 | N/A | -$0.23 | N/A | N/A | N/A | N/A | N/A | N/A |
